13: Trust and confidence in medicine
This seminar will cover a variety of aspects including the basis on which medical decisions are made depending on evidence, ethics and good clinical practice; the generation of a sound base for the advancement of knowledge; the generation of trust in the system as well as trust in progress in the daily practice. Trust in the medical system and in the capabilities of doctors and scientists lies at the core of our societies. Hence, losing that trust of consumers and patients can amount to a severe damage for companies and health care providers (e.g. the Contergan scandal, Vioxx and statins, cases of medical malpractice). Closely linked to the issue of trust is the question about ethics in medical progress. How far do we dare to go? How do the professionals deal with the pressure to combine cutting-edge research with ethic integrity? How do professional associations and the public institutions assure that the trust is not undermined? These topics will be discussed by way of presentations by experts and discussions with the participants.
| |||||
| |||||
| |||||
|
Dr. Christiane DRUML
UNESCO Chair, Bioethics, Medical University of Vienna
| Christiane Druml was born in Vienna and studied law at the University of Vienna. She is currently holding the UNESCO Chair on Bioethics at the Medical University of Vienna and also serves as Director of Ethics, Collections and History of Medicine of the Medical University of Vienna. Since 2016 she is Deputy Director & Key Researcher at the Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases (LBI-RUD). 2007 she has been appointed President of the Austrian National Bioethics Commission by the Austrian Federal Chancellor. Furthermore, she is a member of the Medical Council of the Republic of Austria and serves in many international functions. From 2011 to 2015, she was Vice-Rector for Clinical Affairs at the Vienna Medical University. Before that she has been managing director of the Ethics Committee at the Vienna Medical University (1992-2011). Christiane Druml was Member of the International Bioethics Committee IBC of UNESCO from 2008 to 2015 and serves since 2006 as Austrian Member of the General Assembly of the "European and Developing Countries Clinical Trial Partnership- EDCTP". She has been awarded the Austrian Cross of Honour for Science and Arts, and was named Chevalier de la Légion d’Honneur in 2011. |
Dr. Michael FREISSMUTH
Professor und Vorstand, Institut für Pharmakologie, Medizinische Universität Wien
| 1978-1983 | Medical School, University of Vienna |
| 1983-1987 | Pre- and postdoctoral training, Institute of Pharmacology, University of Vienna (with Wolfgang Schütz) |
| 1984 | M.D. graduation "sub auspiciis praesidentis" University of Vienna |
| 1984-1992 | Training as medical specialist in Pharmacology and Toxicology |
| 1987-1989 | Postdoctoral training, Department of Pharmacology, University of Texas, Southwestern Medical Center Dallas, Tx (with Alfred G. Gilman) |
| 1992 | Clinical rotation, Department of Internal Medicine I, Vienna General Hospital |
| 1995 | Appointment as Professor of Pharmacology, University of Vienna |
| since 2000 | Chairman, Department of Pharmacology, Medical University of Vienna |
Dr. Jacek JASSEM
Head, Department of Oncology and Radiotherapy, Medical University of Gdansk
| Professor of Medicine and Radiation Oncologist at the Medical University of Gdansk in Poland | |
| since 1990 | Head of the Department of Oncology and Radiotherapy at the Medical University of Gdansk |
Dr. Christoph ZIELINSKI
Vorstand, Klinik für Innere Medizin I; Leiter, Klinische Abteilung für Onkologie, Medizinische Universität Wien
| 1970-1976 | Studium an der Medizinischen Fakultät der Universität Wien |
| 1976-1978 | Assistenzarzt am Institut für Immunologie der Universität Wien |
| 1978-1983 | Ausbildung zum Facharzt für Innere Medizin |
| 1979-1980 | Fellow am Cancer Research Center, Tufts University Medical School, Boston, USA |
| 1986 | Habilitation in Klinischer Immunologie |
| 1989 | Erweiterung des Habilitationsfachs auf das Gesamtgebiet der Inneren Medizin |
| 1992 | Ernennung zum außerordentlichen Universitätsprofessor (lt. §31 UOG 1975) für Klinische Immunologie und Innere Medizin unter besonderer Berücksichtigung der internistisch-experimentellen Onkologie |
| 1997 | Wissenschaftlicher Leiter des Ludwig Boltzmann Instituts für klinisch-experimentelle Onkologie (dieses Institut wird interdisziplinär gemeinsam mit den Professoren Ernst Kubista und Hubert Pehamberger geführt) |
| 2000-2004 | Vizedekan der Medizinischen Fakultät der Universität Wien |
| seit 2001 | Leiter der Klinischen Abteilung für Onkologie an der Universitätsklinik für Innere Medizin I |
| seit 2004 | Vorstand der Universitätsklinik für Innere Medizin I |
| seit 2007 | Vizerektor für Klinische Angelegenheiten an der Medizinischen Universität Wien |
